|
|
|
| Electrocardiogram Showing a High P-wave in a Lung Cancer Patient with Tip Malposition of PICC: A Case Report |
| Chunli LIU1, Liyong XU2, Dingbiao JIANG1, Ruchun SHI1, Jing MAO1, Lagen LIU1, Chuanyin CHEN1, Tao JIN3, Aifeng MENG3 |
| 1Department of Vascular Access Center, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China; 2Department of General Surgery, Nanjing Agriculture University Hospital, Nanjing 210009, China; 3Department of nursing, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China |
|
|
|
|
Abstract Background: It is recommended that electrocardiogram (EKG) showed a high P wave change, post-operation chest X-ray (CXR) should not be needed to confirm the tip of PICC location. However, in this case, the EKG showed a high P-wave change; a followed CXR revealed the tip malposition in the superior vena cava (SVC).
Methods: A power PICC was placed under the ultrasound-guided modified seldinger technique in a 55-year-old man with Lung cancer. Postoperative CXR revealed that the catheter tip was ectopic in the SVC. EKG was used for adjusting the malposition, EKG showed a P-wave elevation. However, a followed CXR revealed that the tip of the catheter was still ectopic in the SVC. We conducted the second adjustment. The amplitude change of P-wave was observed from standard to high-peak and then to a downward deflection on the leading edge of the P-wave. The catheter tip was correct in the lower third of SVC.
Results: We successfully adjusted the malposition of PICC with the EKG method.
Conclusion: There is a risk that we cannot recognize the PCC tip malposition in the SVC with EKG, we must observe the typical P-wave change from standard to high peak and then to biphasic.
|
|
|
|
Corresponding Authors:
Tao JIN, E-mail: 13832790@qq.com; Aifeng MENG, E-mail: baiziting2018@163.com
|
|
|
|
| [1] |
Yue WANG, Juan NAN. Final Overall Survival Results from the FLAURA Trial: a Phase III Study on Osimertinib in EGFRMutated Advanced Non-small Cell Lung Cancer[J]. Journal of International Translational Medicine, 2020, 8(2): 27-29. |
| [2] |
. JITM Table of Contents Volume 2, Number 2, 2020[J]. Journal of International Translational Medicine, 2020, 8(2): 39-. |
| [3] |
Hamidreza FAMITAFRESHI1, Morteza KARIMIAN2. Neurogenesis is a Proper Target for Controlling Feeding Behavior and Obesity[J]. Journal of International Translational Medicine, 2020, 8(2): 38-38. |
| [4] |
Rozaliya HRISTOVA1, Yani ZDRAVKOV1, Maria HRISTOVA2, Ivan TANEV1. Treatment of Limbal Stem Cell Deficiency in the Setting of Neurotrophic Keratopathy[J]. Journal of International Translational Medicine, 2020, 8(2): 30-37. |
| [5] |
Saeideh ERFANIAN, Fatemeh RAHMANIAN, Abdolreza Sotoodeh JAHROMI, Mohammad HOJJAT-FARSANGI. Non-association between rs17568 OX40 Gene Polymorphism and Type-2 Diabetes Mellitus, West-south of Iran[J]. Journal of International Translational Medicine, 2020, 8(1): 19-22. |
| [6] |
Mohammad NASR-ESFAHANI, Elham ESMAEILI, Reza AZIZKHANI, Farhad HEYDARI, Babak MASOUMI. Efficiency of Magnesium Sulfate versus Succinylcholine in Rapid Sequence Intubation[J]. Journal of International Translational Medicine, 2020, 8(1): 8-12. |
|
|
|
|
